Skip to main content

ZNF45 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86492

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-86492-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of human ZNF45. Peptide sequence: FCSQIWQQITRELIKYQDSVVNIQRTGCQLEKRDDLHYKDEGFSNQSSHL The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for ZNF45 Antibody

Western Blot: ZNF45 Antibody [NBP2-86492]

Western Blot: ZNF45 Antibody [NBP2-86492]

Western Blot: ZNF45 Antibody [NBP2-86492] - WB Suggested Anti-ZNF45 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human Lung

Applications for ZNF45 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ZNF45

ZNF45 may be involved in transcriptional regulation

Alternate Names

HZF1Zinc finger protein HZF1, KIAA2007, zinc finger protein 1, zinc finger protein 266

Gene Symbol

ZNF45

Additional ZNF45 Products

Product Documents for ZNF45 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ZNF45 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...